NCT05820477 (FAMS-T1D) is a NA clinical trial of FAMS-T1D in Type 1 Diabetes, sponsored by University of Utah.

Who is sponsoring NCT05820477?

NCT05820477 is sponsored by University of Utah.

What drugs are being tested in NCT05820477?

Interventions in NCT05820477: FAMS-T1D, Digital resources for diabetes.

What condition does NCT05820477 study?

NCT05820477 studies Type 1 Diabetes.

Is NCT05820477 still recruiting?

NCT05820477 is currently active, enrolled. Last updated 13 November 2025.

Last reviewed 2025-11-13 · How we verify

NCT05820477: FAMS-T1D

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FAMS-T1D Self-Regulation and Social Support for T1D

Active, enrolled NA Last updated 13 November 2025

What this trial tests

NA trial testing FAMS-T1D in Type 1 Diabetes in 280 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

25 April 2023

Primary endpoint
31 January 2027

30 April 2027

Quick facts

Lead sponsor	University of Utah
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	basic science
Enrollment	280
Start date	25 April 2023
Primary completion	31 January 2027
Estimated completion	30 April 2027
Sites	2 locations across United States

Drugs / interventions tested

FAMS-T1D
Digital resources for diabetes

Conditions studied

Type 1 Diabetes — all drugs for Type 1 Diabetes →

Sponsor

University of Utah

Who can join

Adults 18 to 24, any sex, with Type 1 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to evaluate how effective the FAMS-T1D intervention is for improving self-regulation (e.g., setting and meeting goals for type 1 diabetes) and social support for meeting those goals for young adults. The main questions that are examined include 1) whether the intervention improves blood glucose, self-management and diabetes distress across time, 2) whether these improvements occur through better self-regulation and social-regulation, 3) whether the intervention improves outcomes for support persons (a friend or family member invited to participate by the person with diabetes) without increasing support burden and 4) whether the intervention improves for persons with diabetes who are on continuous blood glucose monitor their time in range.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of FAMS-T1D

Trials testing the same drug.

NCT05854069 — Adapting FAMS to Optimize CGM Use Among Emerging Adults With Type 1 Diabetes · NA · active not recruiting

Other recruiting trials for Type 1 Diabetes

Currently open trials in the same condition.

NCT07061574 — A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New On · Phase 1, PHASE2 · recruiting
NCT07360080 — Long-Term Outcomes of Teplizumab in Routine Clinical Care · recruiting
NCT07457580 — Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs) · recruiting
NCT07212179 — Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 · NA · recruiting
NCT07287943 — To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes. · NA · recruiting

Other University of Utah trials

Trials by the same sponsor.

NCT07515755 — Supplemental Oxygen and Oxygen Desaturations in Colonoscopies · NA · not yet recruiting
NCT07225426 — Personalizing Financial Incentives · NA · recruiting
NCT06716411 — Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness · NA · recruiting
NCT07246538 — Positive Airway Pressure (PAP) System Evaluation in Volunteers · NA · not yet recruiting
NCT04208984 — Diversion Device With Breath Control · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05820477 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Utah
Last refreshed: 13 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05820477.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing